Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy
  • ‘Beyond Medical Necessity’ Hospital Stays
  • Trump’s Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas ‘Detransition Clinic’

WHAT'S NEW

  • Vaccine Policy
  • 'Beyond Medical Necessity' Hospital Stays
  • Trump's Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas 'Detransition Clinic'

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 31 2023

Full Issue

Perspectives: Majority Of Counterfeit Scripts Contain Fentanyl; Upadacitinib Proves Effective Against Crohn's

Read recent commentaries about drug-cost issues.

USA Today: 6 Out Of 10 Fake Prescription Pills Are Laced With Fentanyl. Warn Kids

Fentanyl is a lab-made opioid developed to treat severe pain. Like other opioids, it’s extremely effective − and extremely addictive. As the opioid crisis raged through the mid-1990s, people addicted to prescription opioids turned to the street. (Tracy Vonder Brink, 5/30)

New England Journal of Medicine: JAK1 Inhibition To Treat Crohn’s Disease 

In this issue of the Journal, Loftus et al.1 report the results of three trials of upadacitinib (a small-molecule drug that inhibits the Janus kinase [JAK] 1 [JAK1] protein) for the treatment of moderate-to-severe Crohn’s disease, an inflammatory bowel disease (IBD). Two were trials of induction therapy, and one was a trial of maintenance therapy. (Maria T. Abreu, M.D., 5/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF